Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Melissa Mahoney to Humans

This is a "connection" page, showing publications Melissa Mahoney has written about Humans.

 
Connection Strength
 
 
 
0.077
 
  1. Milligan ED, Penzkover KR, Soderquist RG, Mahoney MJ. Spinal interleukin-10 therapy to treat peripheral neuropathic pain. Neuromodulation. 2012 Nov-Dec; 15(6):520-6; discussion 526.
    View in: PubMed
    Score: 0.011
  2. Mason MN, Mahoney MJ. A novel composite construct increases the vascularization potential of PEG hydrogels through the incorporation of large fibrin ribbons. J Biomed Mater Res A. 2010 Oct; 95(1):283-93.
    View in: PubMed
    Score: 0.010
  3. Soderquist RG, Milligan ED, Harrison JA, Chavez RA, Johnson KW, Watkins LR, Mahoney MJ. PEGylation of interleukin-10 for the mitigation of enhanced pain states. J Biomed Mater Res A. 2010 Jun 01; 93(3):1169-79.
    View in: PubMed
    Score: 0.010
  4. Soderquist RG, Mahoney MJ. Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics. Expert Opin Drug Deliv. 2010 Mar; 7(3):285-93.
    View in: PubMed
    Score: 0.010
  5. Bjugstad KB, Redmond DE, Lampe KJ, Kern DS, Sladek JR, Mahoney MJ. Biocompatibility of PEG-based hydrogels in primate brain. Cell Transplant. 2008; 17(4):409-15.
    View in: PubMed
    Score: 0.008
  6. Alsberg E, von Recum HA, Mahoney MJ. Environmental cues to guide stem cell fate decision for tissue engineering applications. Expert Opin Biol Ther. 2006 Sep; 6(9):847-66.
    View in: PubMed
    Score: 0.008
  7. Mahoney MJ, Saltzman WM. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. Proc Natl Acad Sci U S A. 1999 Apr 13; 96(8):4536-9.
    View in: PubMed
    Score: 0.004
  8. Mahoney MJ, Saltzman WM. Cultures of cells from fetal rat brain: methods to control composition, morphology, and biochemical activity. Biotechnol Bioeng. 1999 Feb 20; 62(4):461-7.
    View in: PubMed
    Score: 0.004
  9. Mahoney MJ, Saltzman WM. Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders. J Pharm Sci. 1996 Dec; 85(12):1276-81.
    View in: PubMed
    Score: 0.004
  10. Amer LD, Holtzinger A, Keller G, Mahoney MJ, Bryant SJ. Enzymatically degradable poly(ethylene glycol) hydrogels for the 3D culture and release of human embryonic stem cell derived pancreatic precursor cell aggregates. Acta Biomater. 2015 Aug; 22:103-10.
    View in: PubMed
    Score: 0.003
  11. Amer LD, Mahoney MJ, Bryant SJ. Tissue engineering approaches to cell-based type 1 diabetes therapy. Tissue Eng Part B Rev. 2014 Oct; 20(5):455-67.
    View in: PubMed
    Score: 0.003
  12. Saltzman WM, Mak MW, Mahoney MJ, Duenas ET, Cleland JL. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems. Pharm Res. 1999 Feb; 16(2):232-40.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)